Vontobel Holding
KRYS icon

Vontobel Holding’s Krystal Biotech KRYS Stock Holding History

Vontobel Holding’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-600
Closed -$106K – 1483
2025
Q3 		$106K Buy
+600
New +$89.8K ﹤0.01% 1284

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vontobel Holding's KRYS Position: Q1 2026 in Review

Vontobel Holding reduced its Krystal Biotech (KRYS) stake by 1.7% in Q1 2026, selling an estimated $9.85K and leaving 2,118 shares worth $547K. The position accounts for ﹤0.01% of the portfolio, ranked #821.

Vontobel Holding first reported a position in KRYS in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.06M in Q1 2021. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Vontobel Holding held 2,118 shares of Krystal Biotech worth $547K as of Q1 2026.
  • Vontobel Holding sold 37 Krystal Biotech shares in Q1 2026, an estimated $9.85K.
  • Krystal Biotech made up ﹤0.01% of Vontobel Holding's portfolio in Q1 2026, its #821 holding.
  • Vontobel Holding first reported a position in Krystal Biotech in Q4 2020 and has held it in 22 quarters since.
  • Vontobel Holding's Krystal Biotech position peaked at $3.06M in Q1 2021.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.